Atlas Trials

Busulfan, Melphalan and Etoposide as Conditioning for Autologous Transplantation for Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT03792815 · COMPLETED

Trial details

NCT number
NCT03792815
Sponsor
Soonchunhyang University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Hodgkin's Lymphoma
Start date
2009-10-01
Primary completion
2011-11-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.